Date | Title | Symbol | Company Name | Link |
2022-06-01T12:49:26.000Z | Certification of Interim Filings - CFO | XPHYF | XPhyto Therapeutics Corporation | Link |
2022-06-01T12:48:19.000Z | Certification of Interim Filings - CEO | XPHYF | XPhyto Therapeutics Corporation | Link |
2022-06-01T12:45:16.000Z | Management's Discussion and Analysis for the First Quarter Ended March 31, 2022 | XPHYF | XPhyto Therapeutics Corporation | Link |
2022-06-01T12:43:47.000Z | Interim Financial Statements for the First Quarter Ended March 31, 2022 | XPHYF | XPhyto Therapeutics Corporation | Link |
2022-06-01T12:19:37.000Z | CryptoStar Corp. Q1 2022 MDA May 30 2022 | CSTXF | Cryptostar Corp. | Link |
2022-06-01T12:19:05.000Z | CryptoStar Corp. Q1 2022 FS May 30 2022 | CSTXF | Cryptostar Corp. | Link |
2022-06-01T12:14:48.000Z | Q1 2022 Financial Statements | SZLSF | Stagezero Life Sciences Ltd. | Link |
2022-06-01T12:13:50.000Z | Q1 2022 MD&A | SZLSF | Stagezero Life Sciences Ltd. | Link |
2022-06-01T11:19:21.000Z | Three Months Ended March 31, 2022 | KNBIF | Kane Biotech Inc. | Link |
2022-06-01T11:18:00.000Z | Three Months Ended March 31, 2022 | KNBIF | Kane Biotech Inc. | Link |
Attachments
- Original Link
- Original Document
- Permalink
Disclaimer
XPhyto Therapeutics Corp. published this content on 01 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 01 June 2022 13:01:04 UTC.